Jennifer Stevens, Chief Regulatory Officer at TriSalus Life Sciences, Inc. (TLSI), sold 316 shares at $4.39 ($1K) on 2026-10-05, disclosed to the SEC on 2026-10-07.
Open-market sale of $1k TLSI by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |